fludarabine has been researched along with Experimental Neoplasms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Appelhans, D; Borowiec, M; Bryszewska, M; Danilewicz, M; Franiak-Pietryga, I; Jander, M; Kuncman, W; Sikorska, H; Ziemba, B | 1 |
| Appelhans, D; Borowiec, M; Bryszewska, M; Danilewicz, M; Franiak-Pietryga, I; Jander, M; Kuncman, W; Lewkowicz, P; Ostrowska, K; Sikorska, H; Ziemba, B | 1 |
| Biondi, A; Corsi, A; Dazzi, F; Granata, V; Michelozzi, IM; Pievani, A; Rambaldi, B; Serafini, M | 1 |
| Castejon, R; Losada-Fernandez, I; Martinez, A; Morado, M; Perez-Aciego, P; Perez-Chacon, G; Rebolleda, N; Rosado, S; Vallejo-Cremades, MT; Vargas-Nuñez, JA | 1 |
| Aprahamian, M; Deharvengt, S; Hajri, A; Rejiba, S; Wack, S | 1 |
| Faulds, D; McTavish, D; Ross, SR | 1 |
| Brock, WA; Grégoire, V; Hittelman, WN; Hunter, N; Milas, L; Plunkett, W | 1 |
| Brock, WA; Grégoire, V; Hittelman, WN; Milas, L; Plunkett, W; Stephens, LC; Van, NT | 1 |
1 review(s) available for fludarabine and Experimental Neoplasms
| Article | Year |
|---|---|
Fludarabine. A review of its pharmacological properties and therapeutic potential in malignancy.
Topics: Animals; Antineoplastic Agents; Humans; Neoplasms; Neoplasms, Experimental; Vidarabine | 1993 |
7 other study(ies) available for fludarabine and Experimental Neoplasms
| Article | Year |
|---|---|
Anti-Tumour Activity of Glycodendrimer Nanoparticles in a Subcutaneous MEC-1 Xenograft Model of Human Chronic Lymphocytic Leukemia.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bone Marrow; Cell Line, Tumor; Dendrimers; Drug Development; Heterografts; Humans; Immunotherapy; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Mice; Neoplasms, Experimental; Polypropylenes; Tissue Distribution; Trisaccharides; Vidarabine | 2020 |
Maltotriose-modified poly(propylene imine) Glycodendrimers as a potential novel platform in the treatment of chronic lymphocytic Leukemia. A proof-of-concept pilot study in the animal model of CLL.
Topics: Animals; Cell Line, Tumor; Dendrimers; Drug Delivery Systems; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Mice; Mice, Inbred NOD; Neoplasms, Experimental; Pilot Projects; Polypropylenes; Trisaccharides; Vidarabine | 2020 |
Fludarabine as a cost-effective adjuvant to enhance engraftment of human normal and malignant hematopoiesis in immunodeficient mice.
Topics: Animals; Cell Line, Tumor; Graft Survival; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Humans; Mice; Mice, SCID; Neoplasm Transplantation; Neoplasms, Experimental; Transplantation Conditioning; Vidarabine | 2018 |
Synergistic Activity of Deguelin and Fludarabine in Cells from Chronic Lymphocytic Leukemia Patients and in the New Zealand Black Murine Model.
Topics: Age Factors; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Cells, Cultured; Drug Synergism; Female; Humans; Immunoblotting; Immunohistochemistry; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocytes, Mononuclear; Mice, Inbred NZB; Neoplasms, Experimental; NF-kappa B; Proto-Oncogene Proteins c-akt; Rotenone; Signal Transduction; Tumor Cells, Cultured; Vidarabine | 2016 |
Efficient electrogene therapy for pancreatic adenocarcinoma treatment using the bacterial purine nucleoside phosphorylase suicide gene with fludarabine.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Line, Tumor; Electrochemotherapy; Electroporation; Gene Transfer Techniques; Genes, Bacterial; Genes, Transgenic, Suicide; Genetic Therapy; Humans; Neoplasms, Experimental; Pancreatic Neoplasms; Prodrugs; Purine-Nucleoside Phosphorylase; Rats; Rats, Inbred Lew; RNA, Messenger; Vidarabine; Xenograft Model Antitumor Assays | 2007 |
Fludarabine improves the therapeutic ratio of radiotherapy in mouse tumors after single-dose irradiation.
Topics: Animals; Antineoplastic Agents; Male; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Radiation-Sensitizing Agents; Radiotherapy; Radiotherapy Dosage; Vidarabine | 1994 |
The role of fludarabine-induced apoptosis and cell cycle synchronization in enhanced murine tumor radiation response in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; DNA; Dose-Response Relationship, Drug; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Radiation Tolerance; S Phase; Vidarabine | 1994 |